These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8042198)

  • 21. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study.
    Kjos SL; Shoupe D; Douyan S; Friedman RL; Bernstein GS; Mestman JH; Mishell DR
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1822-7. PubMed ID: 2256489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect on blood coagulation and fibrinolysis in women using norethisterone or a combination of ethinyloestradiol and quingestianol.
    Korsan-Bengtsen K; Larsson B
    Gynecol Obstet Invest; 1978; 9(6):312-8. PubMed ID: 754993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
    Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in endogenous fibrinolysis and platelet activity during exercise in young volunteers.
    Beisiegel B; Treese N; Hafner G; Meyer J; Darius H
    Agents Actions Suppl; 1992; 37():183-9. PubMed ID: 1378684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What does the micropill bring?].
    Mall-Haefeli M
    Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytogenetic study of blood in women who had used oral contraceptives.
    Fridrichová I
    Neoplasma; 1990; 37(5):545-53. PubMed ID: 1700312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptives and blood coagulation.
    Bonnar J; Sabra AM
    J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill.
    Hodsman GP; Robertson JI; Semple PF; Mackay A
    Eur Heart J; 1982 Jun; 3(3):255-9. PubMed ID: 6809465
    [No Abstract]   [Full Text] [Related]  

  • 32. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated angiitis of the brain in a young female on the contraceptive pill.
    Nagaratnam N; James WE
    Postgrad Med J; 1987 Dec; 63(746):1085-6. PubMed ID: 3451235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of contraceptive pills and intrauterine devices on urinary bladder.
    Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
    Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acceptability of hormonal contraceptives with a low steroid content].
    Dubnitskaia LV
    Akush Ginekol (Mosk); 1988 Aug; (8):47-50. PubMed ID: 3195708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptives and panic disorder.
    Deci PA; Lydiard RB; Santos AB; Arana GW
    J Clin Psychiatry; 1992 May; 53(5):163-5. PubMed ID: 1592843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical reserve cell hyperplasia of cervical glands, simulating adenocarcinoma. An undescribed reversible lesion in a woman taking oral contraceptives.
    Filotico M; Grasso S
    Tumori; 1981 Oct; 67(5):491-6. PubMed ID: 7324178
    [No Abstract]   [Full Text] [Related]  

  • 40. The relationship between vascular headaches and low-dose oral contraceptives.
    Karsay K
    Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.